Page 46 - GlaxoSmithKline Pharmaceuticals AR 2012

42
Previous year
Rupees
in lakhs
Rupees
in lakhs
5 OTHER LONG TERM LIABILITIES
Deposits received .. .. .. .. .. .. .. .. 4,96.72 4,99.86
TOTAL .. 4,96.72 4,99.86
6 LONG TERM PROVISIONS
For Pricing matters (Refer Note 23) .. .. .. .. .. .. .. 128,34.05 128,34.05
For employee benefits :
Gratuity .. .. .. .. .. .. .. .. .. 17,20.53 15,88.96
Leave encashment and compensated absences .. .. .. .. .. 25,84.22 23,00.15
Post retirement medical and other benefits .. .. .. .. .. 34,19.75 27,74.83
For long-term incentive plan .. .. .. .. .. .. .. .. 4,28.18 2,76.39
For divestment / restructuring .. .. .. .. .. .. .. .. 16,58.97 17,23.85
For others .. .. .. .. .. .. .. .. .. .. 8,33.59 8,57.55
TOTAL .. 234,79.29 223,55.78
7 TRADE PAYABLES
Sundry creditors :
Micro and Small enterprises (Refer Note 26) .. .. .. .. .. 2,59.00 1,25.40
Others .. .. .. .. .. .. .. .. .. .. 229,93.92 197,08.70
TOTAL .. 232,52.92 198,34.10
8 OTHER CURRENT LIABILITIES
Current Maturity of Long Term Borrowings :
Interest free sales tax loan from SICOM Limited (Refer Note 4) .. .. .. 45.09 31.19
Subsidiary company .. .. .. .. .. .. .. .. .. 1,59.05 1,16.56
Unpaid dividends* .. .. .. .. .. .. .. .. .. 16,75.31 13,74.40
Salaries, wages and bonus payable .. .. .. .. .. .. .. 32,05.77 25,53.90
Statutory dues including provident fund and tax deducted at source .. .. .. 19,26.22 15,25.10
Creditors for capital goods .. .. .. .. .. .. .. .. 4,50.75 1,38.49
Rationalisation relating to a manufacturing site .. .. .. .. .. .. 9,93.37 —
Other Payables .. .. .. .. .. .. .. .. .. 6,23.56 10,97.12
TOTAL .. 90,79.12 68,36.76
* There are no amounts due and outstanding to be credited to Investor Education and
Protection Fund.
Notes to the Financial Statements for the year ended 31st December, 2012 — continued